Dr. Bei Yang is currently the Head of Clinical Pharmacology and Pharmacometrics at Bristol-Myers Squibb R&D China. In her current role she leads the team responsible for clinical pharmacology strategies and studies, development of pharmacometric methods to guide clinical dosing regimens in China. Previously, she worked at companies including Sanofi (China) and A2PG (USA), focusing on research work in early-stage clinical development, clinical pharmacology and pharmacometrics. She received her Ph.D. in Pharmaceutical Sciences under the supervision of Dr. David Smith and M.A. in Statistics both from the University of Michigan, Ann Arbor; she received her bachelor's degree in Pharmacy and master's degree in Pharmaceutical Analysis from Fudan University.

百时美施贵宝中国研发临床药理学和定量药理学部门的负责人。她所领导的团队负责百时美施贵宝中国研发的临床药理策略和研究，定量药理学方法学的开发和建立，以指导中国临床给药方案的决策。此前她曾在赛诺菲（中国）和A2PG（美国）等公司从事早期临床、临床药理和定量药理相关的研发工作。她在密西根大学安娜堡分校的David Smith博士的指导下，获得药物科学博士，并于同校获得统计学硕士学位；在复旦大学获得药学本科和药物分析硕士学位。